{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:29:22Z","timestamp":1793410162476,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000061","name":"the Fogarty International Center","doi-asserted-by":"crossref","award":["D43 TW012274"],"award-info":[{"award-number":["D43 TW012274"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vanderbilt University Medical Center, VUMC to DCH","award":["D43 TW009744"],"award-info":[{"award-number":["D43 TW009744"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46235-0","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:14:01Z","timestamp":1775186041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic syndrome and its risk factors among adults living with HIV receiving antiretroviral therapy in Zambia: an ambidirectional cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Benson M.","family":"Hamooya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bosomprah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepiso K.","family":"Masenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katongo H.","family":"Mutengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chilala","family":"Cheelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukundo","family":"Siame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precious","family":"Simushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuku","family":"Mwakyoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolezya","family":"Mudenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbroad","family":"Mutale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikabasa","family":"Halwiindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bedimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeep","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitalu","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Heimburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"1","key":"46235_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1741-7015-9-48","volume":"9","author":"E Kassi","year":"2011","unstructured":"Kassi, E., Pervanidou, P., Kaltsas, G. & Chrousos, G. Metabolic syndrome: definitions and controversies. BMC Med. 9 (1), 48 (2011).","journal-title":"BMC Med."},{"issue":"1","key":"46235_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/toxsci\/kfx233","volume":"162","author":"DL Mendrick","year":"2018","unstructured":"Mendrick, D. L. et al. Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic. Toxicol. Sci. 162 (1), 36\u201342 (2018).","journal-title":"Toxicol. Sci."},{"issue":"1","key":"46235_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4652-6","volume":"18","author":"K Yeboah","year":"2018","unstructured":"Yeboah, K. et al. Metabolic syndrome and parental history of cardiovascular disease in young adults in urban Ghana. BMC Public. Health. 18 (1), 1\u20138 (2018).","journal-title":"BMC Public. Health"},{"issue":"1","key":"46235_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-020-01166-6","volume":"19","author":"MJ Guembe","year":"2020","unstructured":"Guembe, M. J. et al. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc. Diabetol. 19 (1), 195 (2020).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"46235_CR5","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1186\/s12889-024-20118-3","volume":"24","author":"D Trachunthong","year":"2024","unstructured":"Trachunthong, D., Tipayamongkholgul, M., Chumseng, S., Darasawang, W. & Bundhamcharoen, K. Burden of metabolic syndrome in the global adult HIV-infected population: a systematic review and meta-analysis. BMC Public. Health. 24 (1), 2657 (2024).","journal-title":"BMC Public. Health"},{"issue":"3","key":"46235_CR6","doi-asserted-by":"publisher","first-page":"e0150970","DOI":"10.1371\/journal.pone.0150970","volume":"11","author":"KA Nguyen","year":"2016","unstructured":"Nguyen, K. A., Peer, N., Mills, E. J. & Kengne, A. P. A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population. PLOS ONE. 11 (3), e0150970 (2016).","journal-title":"PLOS ONE"},{"issue":"1","key":"46235_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13643-018-0927-y","volume":"8","author":"OO Todowede","year":"2019","unstructured":"Todowede, O. O., Mianda, S. Z. & Sartorius, B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa\u2014a systematic review and meta-analysis. Syst. Rev. 8 (1), 4 (2019).","journal-title":"Syst. Rev."},{"issue":"1","key":"46235_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/apc.2016.0140","volume":"31","author":"S Naidu","year":"2017","unstructured":"Naidu, S., Ponnampalvanar, S., Kamaruzzaman, S. B. & Kamarulzaman, A. Prevalence of Metabolic Syndrome Among People Living with HIV in Developing Countries: A Systematic Review. AIDS Patient Care STDs. 31 (1), 1\u201313 (2017).","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"46235_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11883-008-0010-6","volume":"10","author":"V Pao","year":"2008","unstructured":"Pao, V., Lee, G. A. & Grunfeld, C. HIV therapy, metabolic syndrome, and cardiovascular risk. Curr. Atheroscler Rep. 10 (1), 61\u201370 (2008).","journal-title":"Curr. Atheroscler Rep."},{"issue":"3","key":"46235_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11904-014-0219-7","volume":"11","author":"LM Nix","year":"2014","unstructured":"Nix, L. M. & Tien, P. C. Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV. Curr. HIV\/AIDS Rep. 11 (3), 271\u2013278 (2014).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"46235_CR11","first-page":"507","volume":"12","author":"D Thet","year":"2020","unstructured":"Thet, D. & Siritientong, T. Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies. HIVAIDS Auckl. NZ. 12, 507\u2013524 (2020).","journal-title":"HIVAIDS Auckl. NZ"},{"issue":"10144","key":"46235_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","volume":"392","author":"LG Bekker","year":"2018","unstructured":"Bekker, L. G. et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society\u2014Lancet Commission. Lancet Lond. Engl. 392 (10144), 312\u2013358 (2018).","journal-title":"Lancet Lond. Engl."},{"key":"46235_CR13","doi-asserted-by":"publisher","unstructured":"Rebeiro, P. F. et al. Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada. Clin. Infect. Dis. https:\/\/academic.oup.com\/cid\/advance-article\/doi\/https:\/\/doi.org\/10.1093\/cid\/ciaa1403\/5906580 (2020).","DOI":"10.1093\/cid\/ciaa1403\/5906580"},{"issue":"10","key":"46235_CR14","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1016\/S2352-3018(24)00183-8","volume":"11","author":"N Pantazis","year":"2024","unstructured":"Pantazis, N. et al. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration. Lancet HIV. 11 (10), e660\u2013e669 (2024).","journal-title":"Lancet HIV"},{"issue":"6","key":"46235_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11904-024-00708-x","volume":"21","author":"S Savinelli","year":"2024","unstructured":"Savinelli, S., Newman, E. & Mallon, P. W. G. Metabolic Complications Associated with Use of Integrase Strand Transfer Inhibitors (InSTI) for the Treatment of HIV-1 Infection: Focus on Weight Changes, Lipids, Glucose and Bone Metabolism. Curr. HIV\/AIDS Rep. 21 (6), 293\u2013308 (2024).","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"14","key":"46235_CR16","doi-asserted-by":"publisher","first-page":"e25236","DOI":"10.1097\/MD.0000000000025236","volume":"100","author":"BM Hamooya","year":"2021","unstructured":"Hamooya, B. M. et al. Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: Prevalence and associated factors. Med. (Baltim). 100 (14), e25236 (2021).","journal-title":"Med. (Baltim)."},{"issue":"1","key":"46235_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cei.12814","volume":"187","author":"M Nasi","year":"2017","unstructured":"Nasi, M. et al. Ageing and inflammation in patients with HIV infection. Clin. Exp. Immunol. 187 (1), 44\u201352 (2017).","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"46235_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12889-016-3973-1","volume":"17","author":"MJ Kruger","year":"2017","unstructured":"Kruger, M. J. & Nell, T. A. The prevalence of the metabolic syndrome in a farm worker community in the Boland district, South Africa. BMC Public. Health. 17 (1), 61 (2017).","journal-title":"BMC Public. Health"},{"issue":"1","key":"46235_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s40200-021-00815-1","volume":"20","author":"T Jemere","year":"2021","unstructured":"Jemere, T. & Kefale, B. Metabolic syndrome and its associated factors in Ethiopia: A systematic review and meta-analysis. J. Diabetes Metab. Disord. 20 (1), 1021\u20131031 (2021).","journal-title":"J. Diabetes Metab. Disord"},{"issue":"1","key":"46235_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12916-022-02639-z","volume":"20","author":"E Haeuser","year":"2022","unstructured":"Haeuser, E. et al. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000\u20132018. BMC Med. 20 (1), 488 (2022).","journal-title":"BMC Med."},{"key":"46235_CR21","doi-asserted-by":"crossref","unstructured":"Alberti, K. G. M. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120(16):1640\u20135. (2009).","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"46235_CR22","unstructured":"WHO. World Health Organization global strategy for the surveillance and monitoring of HIV drug resistance: An update (World Health Organization, 2012)."},{"issue":"24","key":"46235_CR23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull, F. C. et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 54 (24), 1451\u20131462 (2020).","journal-title":"Br. J. Sports Med."},{"issue":"1","key":"46235_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2288-14-82","volume":"14","author":"W Chen","year":"2014","unstructured":"Chen, W., Shi, J., Qian, L. & Azen, S. P. Comparison of robustness to outliers between robust poisson models and log-binomial models when estimating relative risks for common binary outcomes: a simulation study. BMC Med. Res. Methodol. 14 (1), 82 (2014).","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"46235_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12874-018-0519-5","volume":"18","author":"W Chen","year":"2018","unstructured":"Chen, W., Qian, L., Shi, J. & Franklin, M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med. Res. Methodol. 18 (1), 63 (2018).","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"46235_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1258\/095646207780132415","volume":"18","author":"R Palacios","year":"2007","unstructured":"Palacios, R., Santos, J., Gonz\u00e1lez, M., Ruiz, J. & M\u00e1rquez, M. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy. Int. J. STD AIDS. 18 (3), 184\u2013187 (2007).","journal-title":"Int. J. STD AIDS"},{"key":"46235_CR27","unstructured":"Hsu, J. Y. et al. Weight and metabolic changes among virally-suppressed people living with HIV who switched to co-formulated bictegravir\/emtricitabine\/tenofovir alafenamide. J. Glob Antimicrob. Resist. S2213 (2023). -7165(23)00181-9."},{"issue":"1","key":"46235_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4314\/ahs.v22i1.50","volume":"22","author":"E Ojong","year":"2022","unstructured":"Ojong, E. et al. Metabolic syndrome and its components among HIV\/AIDS patients on Antiretroviral Therapy and ART-Na\u00efve Patients at the University of Calabar Teaching Hospital, Calabar, Nigeria. Afr. Health Sci. 22 (1), 410\u2013417 (2022).","journal-title":"Afr. Health Sci."},{"issue":"1","key":"46235_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12902-023-01419-x","volume":"23","author":"J Jumare","year":"2023","unstructured":"Jumare, J. et al. Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study. BMC Endocr. Disord. 23 (1), 160 (2023).","journal-title":"BMC Endocr. Disord"},{"issue":"2","key":"46235_CR30","doi-asserted-by":"publisher","first-page":"2295435","DOI":"10.1080\/07853890.2023.2295435","volume":"55","author":"M Jemal","year":"2023","unstructured":"Jemal, M. et al. Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study. Ann. Med. 55 (2), 2295435 (2023).","journal-title":"Ann. Med."},{"key":"46235_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s12879-023-08587-0","volume":"23","author":"X Li","year":"2023","unstructured":"Li, X. et al. Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy. BMC Infect. Dis. 23, 598 (2023).","journal-title":"BMC Infect. Dis."},{"key":"46235_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.11604\/pamj.2023.45.63.39461","volume":"45","author":"ML Mashi","year":"2023","unstructured":"Mashi, M. L. et al. [Interventional study on Dolutegravir and other antiretrovirals in patients with subclinical atherosclerosis in the Kinshasa Hospital]. Pan Afr. Med. J. 45, 63 (2023).","journal-title":"Pan Afr. Med. J."},{"issue":"2","key":"46235_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5501\/wjv.v4.i2.56","volume":"4","author":"J da Cunha","year":"2015","unstructured":"da Cunha, J., Maselli, L. M. F., Stern, A. C. B., Spada, C. & Bydlowski, S. P. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J. Virol. 4 (2), 56\u201377 (2015).","journal-title":"World J. Virol."},{"issue":"10","key":"46235_CR34","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/ijms23105592","volume":"23","author":"AS Jim\u00e9nez-Osorio","year":"2022","unstructured":"Jim\u00e9nez-Osorio, A. S. et al. Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals. Int. J. Mol. Sci. 23 (10), 5592 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"46235_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/cells10020410","volume":"10","author":"A Gruevska","year":"2021","unstructured":"Gruevska, A. et al. Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment. Cells 10 (2), 410 (2021).","journal-title":"Cells"},{"issue":"7","key":"46235_CR36","doi-asserted-by":"publisher","first-page":"e1000981","DOI":"10.1371\/journal.ppat.1000981","volume":"6","author":"TM Hanley","year":"2010","unstructured":"Hanley, T. M., Blay Puryear, W., Gummuluru, S. & Viglianti, G. A. PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. PLoS Pathog. 6 (7), e1000981 (2010).","journal-title":"PLoS Pathog"},{"issue":"20","key":"46235_CR37","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1128\/JVI.00789-11","volume":"85","author":"TM Hanley","year":"2011","unstructured":"Hanley, T. M. & Viglianti, G. A. Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms. J. Virol. 85 (20), 10834\u201310850 (2011).","journal-title":"J. Virol."},{"issue":"6","key":"46235_CR38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/03630242.2019.1688445","volume":"60","author":"MA Moreira","year":"2020","unstructured":"Moreira, M. A. et al. Metabolic syndrome (MetS) and associated factors in middle-aged women: a cross-sectional study in Northeast Brazil. Women Health. 60 (6), 601\u2013617 (2020).","journal-title":"Women Health"},{"issue":"11","key":"46235_CR39","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1177\/0956462418775188","volume":"29","author":"M Duro","year":"2018","unstructured":"Duro, M. et al. Metabolic syndrome in human immunodeficiency virus-infected patients. Int. J. STD AIDS. 29 (11), 1089\u20131097 (2018).","journal-title":"Int. J. STD AIDS"},{"key":"46235_CR40","doi-asserted-by":"crossref","unstructured":"Kondo, H. et al. Insulin Sensitivity Initially Worsens but Later Improves With Aging in Male C57BL\/6\u00a0N Mice. Anderson RM, editor. J. Gerontol. Ser. A. 78(10) 1785\u201392. (2023).","DOI":"10.1093\/gerona\/glad126"},{"key":"46235_CR41","doi-asserted-by":"publisher","first-page":"679492","DOI":"10.3389\/fendo.2021.679492","volume":"12","author":"C Marmentini","year":"2021","unstructured":"Marmentini, C. et al. Aging Reduces Insulin Clearance in Mice. Front. Endocrinol. 12, 679492 (2021).","journal-title":"Front. Endocrinol."},{"issue":"7","key":"46235_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/CIRCRESAHA.118.312806","volume":"123","author":"CW Chia","year":"2018","unstructured":"Chia, C. W., Egan, J. M. & Ferrucci, L. Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk. Circ. Res. 123 (7), 886\u2013904 (2018).","journal-title":"Circ. Res."},{"issue":"5","key":"46235_CR43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.14336\/AD.2019.1025","volume":"11","author":"P Zhang","year":"2020","unstructured":"Zhang, P. et al. Trends in LDL-C and Non-HDL-C Levels with Age. Aging Dis. 11 (5), 1046 (2020).","journal-title":"Aging Dis."},{"key":"46235_CR44","unstructured":"Spitler, K. M. & Davies, B. S. J. Aging and plasma triglyceride metabolism. J. Lipid. Res. https:\/\/www.semanticscholar.org\/paper\/Aging-and-plasma-triglyceride-metabolism-Spitler-Davies\/3d95c52f47ef3fefe60ecdd6049a72f386f0b233 (2020)."},{"issue":"6","key":"46235_CR45","doi-asserted-by":"publisher","first-page":"e13048","DOI":"10.1111\/acel.13048","volume":"18","author":"AA Johnson","year":"2019","unstructured":"Johnson, A. A. & Stolzing, A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell. 18 (6), e13048 (2019).","journal-title":"Aging Cell."},{"key":"46235_CR46","unstructured":"Costa, C. R. B. et al. Metabolic syndrome in people living with HIV: criteria prevalence and agreement. Acta Paul Enferm ;34. (2021)."},{"issue":"1","key":"46235_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13098-018-0312-y","volume":"10","author":"DD Bosho","year":"2018","unstructured":"Bosho, D. D. et al. Prevalence and predictors of metabolic syndrome among people living with human immunodeficiency virus (PLWHIV). Diabetol. Metab. Syndr. 10 (1), 10 (2018).","journal-title":"Diabetol. Metab. Syndr."},{"key":"46235_CR48","doi-asserted-by":"publisher","unstructured":"Rochlani, Y., Andries, G., Yandrapalli, S., Pothineni, N. V. & Mehta, J. L. Gender Differences in Metabolic Syndrome. In: Mehta JL, McSweeney J, editors. Gender Differences in the Pathogenesis and Management of Heart Disease. Cham: Springer International Publishining, pp. 15\u201333 https:\/\/doi.org\/10.1007\/978-3-319-71135-5_2. (2018).","DOI":"10.1007\/978-3-319-71135-5_2"},{"issue":"2","key":"46235_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejim.2008.06.011","volume":"20","author":"GD Kolovou","year":"2009","unstructured":"Kolovou, G. D. et al. Gender differences in the lipid profile of dyslipidemic subjects. Eur. J. Intern. Med. 20 (2), 145\u2013151 (2009).","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"46235_CR50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12933-023-02046-5","volume":"22","author":"H Yuge","year":"2023","unstructured":"Yuge, H. et al. Triglycerides\/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10. Cardiovasc. Diabetol. 22 (1), 308 (2023).","journal-title":"Cardiovasc. Diabetol."},{"issue":"Supplement_2","key":"46235_CR51","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1086\/375885","volume":"37","author":"S Grinspoon","year":"2003","unstructured":"Grinspoon, S. Mechanisms and Strategies for Insulin Resistance in Acquired Immune Deficiency Syndrome. Clin. Infect. Dis. 37 (Supplement_2), S85\u201390 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"46235_CR52","doi-asserted-by":"publisher","unstructured":"Pedro, M. N. et al. Insulin Resistance in HIV-Patients: Causes and Consequences. Front Endocrinol. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fendo.2018.00514 (2018).","DOI":"10.3389\/fendo.2018.00514"},{"key":"46235_CR53","unstructured":"Vemulapalli, A. C. et al. The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review. Cureus 15(10):e47730 ."},{"issue":"3","key":"46235_CR54","doi-asserted-by":"publisher","first-page":"e0264792","DOI":"10.1371\/journal.pone.0264792","volume":"17","author":"F Mulindwa","year":"2022","unstructured":"Mulindwa, F. et al. Association between integrase strand transfer inhibitor (INSTIs) use with insulin resistance and incident diabetes mellitus in persons living with HIV: A systematic review and meta-analysis protocol. PloS One. 17 (3), e0264792 (2022).","journal-title":"PloS One"},{"key":"46235_CR55","doi-asserted-by":"publisher","first-page":"2050313X2210794","DOI":"10.1177\/2050313X221079444","volume":"10","author":"AT Hirigo","year":"2022","unstructured":"Hirigo, A. T., Gutema, S., Eifa, A. & Ketema, W. Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus. SAGE Open. Med. Case Rep. 10, (2022).","journal-title":"SAGE Open. Med. Case Rep."},{"issue":"1","key":"46235_CR56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12879-022-07091-1","volume":"22","author":"R Bai","year":"2022","unstructured":"Bai, R., Lv, S., Wu, H. & Dai, L. Effects of different integrase strand transfer inhibitors on body weight in patients with HIV\/AIDS: a network meta-analysis. BMC Infect. Dis. 22 (1), 118 (2022).","journal-title":"BMC Infect. Dis."},{"key":"46235_CR57","doi-asserted-by":"publisher","first-page":"120948","DOI":"10.1016\/j.lfs.2022.120948","volume":"308","author":"P Domingo","year":"2022","unstructured":"Domingo, P. et al. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. Life Sci. 308, 120948 (2022).","journal-title":"Life Sci."},{"issue":"Suppl 2","key":"46235_CR58","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8 (Suppl 2), S3 (2006).","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"46235_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11906-014-0507-z","volume":"17","author":"CD Miguel","year":"2015","unstructured":"Miguel, C. D., Rudemiller, N. P., Abais, J. M. & Mattson, D. L. Inflammation and hypertension: new understandings and potential therapeutic targets. Curr. Hypertens. Rep. 17 (1), 507 (2015).","journal-title":"Curr. Hypertens. Rep."},{"key":"46235_CR60","doi-asserted-by":"publisher","unstructured":"Chamarthi, B. et al. Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium and the Renin-Angiotensin System in Humans. Am. J. Hypertens. 24 (10). https:\/\/doi.org\/10.1038\/ajh.2011.113 (2011).","DOI":"10.1038\/ajh.2011.113"},{"issue":"6","key":"46235_CR61","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciz999","volume":"71","author":"PE Sax","year":"2020","unstructured":"Sax, P. E. et al. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. Clin. Infect. Dis. 71 (6), 1379\u20131389 (2020).","journal-title":"Clin. Infect. Dis. Off Publ Infect. Dis. Soc. Am."},{"issue":"2","key":"46235_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-022-00600-6","volume":"19","author":"CE Diggins","year":"2022","unstructured":"Diggins, C. E., Russo, S. C. & Lo, J. Metabolic Consequences of Antiretroviral Therapy. Curr. HIV\/AIDS Rep. 19 (2), 141\u2013153 (2022).","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"8","key":"46235_CR63","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/v14081677","volume":"14","author":"N Pantazis","year":"2022","unstructured":"Pantazis, N. et al. Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug. Viruses 14 (8), 1677 (2022).","journal-title":"Viruses"},{"key":"46235_CR64","doi-asserted-by":"crossref","unstructured":"Liu, M. et al. Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China. HIV Med. (2023).","DOI":"10.1111\/hiv.13605"},{"issue":"12","key":"46235_CR65","doi-asserted-by":"publisher","first-page":"e069637","DOI":"10.1136\/bmjopen-2022-069637","volume":"13","author":"AA Abdela","year":"2023","unstructured":"Abdela, A. A. et al. Prevalence and risk factors of metabolic syndrome in Ethiopia: describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study. BMJ Open. 13 (12), e069637 (2023).","journal-title":"BMJ Open."},{"issue":"4","key":"46235_CR66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.pharma.2021.01.005","volume":"79","author":"A Aouam","year":"2021","unstructured":"Aouam, A. et al. [Metabolic syndrome among people with HIV in central Tunisia: Prevalence and associated factors]. Ann. Pharm. Fr. 79 (4), 465\u2013472 (2021).","journal-title":"Ann. Pharm. Fr."},{"issue":"1","key":"46235_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/ijph.ijph_1060_22","volume":"67","author":"P Shidhaye","year":"2023","unstructured":"Shidhaye, P., Ghate, M., Gurav, S., Gupte, M. D. & Panda, S. Metabolic syndrome in people living with antiretroviral therapy: A cross-sectional investigation from Pune, India. Indian J. Public. Health. 67 (1), 84\u201391 (2023).","journal-title":"Indian J. Public. Health"},{"issue":"2","key":"46235_CR68","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed, G. et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 23 (2), 786 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"46235_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait, A. & den Hartigh, L. J. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front. Cardiovasc. Med. 7, 22 (2020).","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"46235_CR70","doi-asserted-by":"publisher","first-page":"600","DOI":"10.25122\/jml-2021-0153","volume":"14","author":"HA Al-hussaniy","year":"2021","unstructured":"Al-hussaniy, H. A., Alburghaif, A. H. & Naji, M. A. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J. Med. Life. 14 (5), 600\u2013605 (2021).","journal-title":"J. Med. Life"},{"issue":"12","key":"46235_CR71","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.3390\/ijms22126445","volume":"22","author":"VA Genchi","year":"2021","unstructured":"Genchi, V. A. et al. Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine? Int. J. Mol. Sci. 22 (12), 6445 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"46235_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12986-020-00513-4","volume":"17","author":"Y Xiao","year":"2020","unstructured":"Xiao, Y., Liu, D., Cline, M. A. & Gilbert, E. R. Chronic stress, epigenetics, and adipose tissue metabolism in the obese state. Nutr. Metab. 17 (1), 88 (2020).","journal-title":"Nutr. Metab."},{"issue":"1","key":"46235_CR73","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12916-022-02672-y","volume":"20","author":"H Kolb","year":"2022","unstructured":"Kolb, H. Obese visceral fat tissue inflammation: from protective to detrimental? BMC Med. 20 (1), 494 (2022).","journal-title":"BMC Med."},{"issue":"9","key":"46235_CR74","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s11695-020-04593-2","volume":"30","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Obesity Might Persistently Increase Adrenal Gland Volume: a Preliminary Study. Obes. Surg. 30 (9), 3503\u20133507 (2020).","journal-title":"Obes. Surg."},{"key":"46235_CR75","unstructured":"Young, E. R. & Jialal, I. Biochemistry, Ghrelin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547692\/ (2023)."},{"issue":"9","key":"46235_CR76","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/oby.2004.173","volume":"12","author":"MB Snijder","year":"2004","unstructured":"Snijder, M. B. et al. Independent Association of Hip Circumference with Metabolic Profile in Different Ethnic Groups. Obes. Res. 12 (9), 1370\u20131374 (2004).","journal-title":"Obes. Res."},{"issue":"1","key":"46235_CR77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/met.2010.0045","volume":"9","author":"EG Katz","year":"2011","unstructured":"Katz, E. G. et al. Hip Circumference and Incident Metabolic Risk Factors in Chinese Men and Women: The People\u2019s Republic of China Study. Metab. Syndr. Relat. Disord. 9 (1), 55\u201362 (2011).","journal-title":"Metab. Syndr. Relat. Disord"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46235-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:04:06Z","timestamp":1779354246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46235-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46235"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46235-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for this study was obtained from the Mulungushi University School of Medicine and Health Sciences Research Ethics Committee (MUSoMHS-REC) (Ref. No.:\n                      SMHS-MU3-2022-01\n                      ) and the National Health Research Ethics Board (NHREB) (Ref. No.:\n                      NHREB00001\/2\/08\/2022\n                      ). The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All participants provided written informed consent after being informed about the study\u2019s objectives, procedures, and potential risks and benefits in a language they could understand. Clinical trial registration number: Not applicable, as this study did not involve a clinical trial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15851"}}